FDA ANDA · ANDA084751

DILOR-400

Sponsor: SAVAGE LABS

APPLICATION

ANDA084751

TYPE

ANDA

ORIGINAL APPROVAL

1976-08-16

LATEST ACTION

1995-12-15

ROUTE

ORAL

DOSAGE FORM

TABLET

MARKETING STATUS

Discontinued

Products

DILOR-400Discontinued

DYPHYLLINE 400MG · TABLET · ORAL

1995-12-15Manufacturing (CMC) · Supplement 26AP

1993-03-04Manufacturing (CMC) · Supplement 25AP

1991-09-10Manufacturing (CMC) · Supplement 24AP

1990-04-02Manufacturing (CMC) · Supplement 23AP

1988-11-28Manufacturing (CMC) · Supplement 22AP

1988-11-28Manufacturing (CMC) · Supplement 21AP

1983-01-13Manufacturing (CMC) · Supplement 20AP

1983-01-13Manufacturing (CMC) · Supplement 19AP

1976-08-16OriginalAP

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.